AUROBINDO PHARMA LTD.
Smart Quotes
Trade Value (Rs. in Lacs) | 0.01 |
Dividend Yield(%) | 0.28 |
TTM EPS (Rs.) | 33.56 |
P/E Ratio | 32.47 |
Book Value (Rs.) | 329.19 |
Face Value (Rs.) | 1 |
MCap (Rs. in Mn) | 638350.82 |
Price/Earning (TTM) | 28.11 |
Price/Sales (TTM) | 5.72 |
Price/Book (MRQ) | 3.31 |
PAT Margin (%) | 9.55 |
ROCE (%) | 8.44 |
Management Info :
K Ragunathan - Chairman K Nithyananda Reddy - Managing DirectorRegistered Office :
Address :
Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038
Phone : 040-23736370 / 23747340
Email : info@aurobindo.com
Website : www.aurobindo.com
QTR Dec 23 | ANNUAL 23 | |
---|---|---|
Net Profit | 6237.8 | 12304.1 |
Gross Profit | 6872.2 | 16143.5 |
Operating Profit | 8128.2 | 21646.8 |
Net Sales | 26920.3 | 127922.8 |
Abbott India (BSE)  26946.00 (0.74%) | M.Cap ( in Cr) 57258.37 |
Sanofi India (BSE)  8118.25 (2.06%) | M.Cap ( in Cr) 18696.83 |
Dr. Reddy's Lab (BSE)  6155.15 (1.78%) | M.Cap ( in Cr) 102679.14 |
Divi's Lab (BSE)  3436.75 (2.14%) | M.Cap ( in Cr) 91234.91 |
Glaxosmithkline Phar (BSE)  1943.10 (3.26%) | M.Cap ( in Cr) 32917.29 |
|
NON-INSTITUTION | 6.85 % |
|
PROMOTERS | 51.83 % |
|
FI/BANKS/INSURANCE | 5.53 % |
|
MUTUAL FUNDS/UTI | 14.7 % |
|
GOVERNMENT | 0 % |
|
FII | 0 % |
Scheme Name | Hold(%) |
---|---|
Tata India Pharma & Hea... | 8.72 |
Mirae Asset Healthcare ... | 8.01 |
Aditya Birla SL Pharma ... | 7.79 |
Quant Large & Mid Cap F... | 7.42 |
Quant Mid Cap Fund(G) | 6.69 |
Quant ELSS Tax Saver Fu... | 6.20 |